TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 37 filers reported holding TRACON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,819 | -96.4% | 15,835 | -62.2% | 0.00% | – |
| Q1 2023 | $79,141 | +259.7% | 41,874 | +224.1% | 0.00% | – |
| Q3 2022 | $22,000 | -71.8% | 12,919 | -66.8% | 0.00% | – |
| Q2 2022 | $78,000 | -52.4% | 38,900 | -37.7% | 0.00% | – |
| Q1 2022 | $164,000 | -74.3% | 62,400 | -72.9% | 0.00% | – |
| Q4 2021 | $638,000 | +120.0% | 230,058 | +206.7% | 0.00% | – |
| Q3 2021 | $290,000 | +20.8% | 75,000 | +102.7% | 0.00% | – |
| Q2 2021 | $240,000 | -53.6% | 37,000 | -41.1% | 0.00% | – |
| Q1 2021 | $517,000 | – | 62,786 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 4,764,508 | $9,004,920 | 2.70% |
| Ikarian Capital, LLC | 2,765,530 | $5,226,851 | 1.19% |
| JOHNSON & JOHNSON | 84,003 | $158,766 | 0.05% |
| X-Square Capital, LLC | 17,743 | $34 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 258,844 | $489,215 | 0.01% |
| LINDEN ADVISORS LP | 454,916 | $859,791 | 0.01% |
| HoyleCohen, LLC | 13,000 | $24,570 | 0.00% |
| MGO ONE SEVEN LLC | 11,780 | $22,264 | 0.00% |
| Bank of New York Mellon Corp | 66,606 | $125,885 | 0.00% |
| Citadel Advisors | 24,700 | $46,683 | 0.00% |